Sofinnova Partners

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.

The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact its collective future. It invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations with a focus on Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. They sit on the boards of their portfolio companies and play an active role from the formation phase alongside entrepreneurs.

It was headquartered in Paris, Ile-de-France in 1972.

Sofinnova Partners, established in 1972 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Advertising, Messaging, App Marketing, Mobile, Digital Media, Telecommunications, Broadcasting, Software, Natural Language Processing, Artificial Intelligence (AI). The organization boasts a portfolio of 324 investments, with an average round size of $27.0M and 67 successful exits. Their recent investments include Blyk, Streamezzo, Qualcomm, I-Source Gestion, Ardian. The highest investment round they participated in was $706.0B. Among their most notable exits are Blyk and Streamezzo. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.